Gerald Reischl
Head of Radiopharmacy
GermanyResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Gerald Reischl is the Head of Radiopharmacy at the University Hospital of Tuebingen, Germany. His research interests encompass advanced imaging techniques in nuclear medicine, particularly focusing on PET/MRI and PET/CT modalities. Recent publications include studies on the evaluation of radiopharmaceuticals in cancer diagnostics and novel applications in atherosclerosis and neuroendocrine tumors. He contributes significantly to the advancement of imaging methods for both preclinical and clinical cancer research.
Articles (10)
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Collaborators (14)
Bernd Pichler
University of Tuebingen
Nils Trautwein
University of Tuebingen
Alisha Daniels
MD, MHA; Executive Research Director/Assistant Professor
Washington University in St. Louis
Dominik Sonanini
University of Tübingen
Robert Feil
University of Tübingen
Kazushi Suzuki
The Univeristy of Tokyo
Susanne Feil
University of Tübingen
Nick Fox
Professor and Head of Department
UCL Institute of Neurology, University College London
Fabian P Schmidt
-
Brian Gordon
Assistant Professor
Washington University in Saint Louis School of Medicine
Kristina Herfert
Associate Professor for Functional and Metabolic Brain Imaging
University of Tübingen
Qing Wang
Assistant Professor
Washington University in St. Louis
Nelly Joseph-Mathurin
Assistant Professor
Washington University in St. Louis
Clifford Jack
Professor of Radiology
-
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.